title: Elution behavior of daptomycin-loaded calcium sulfate pellets: a preliminary study.
abstract: Daptomycin is a new antibiotic active against many resistant Gram-positive organisms and seems an appropriate candidate for local delivery for severe musculoskeletal infections. Calcium sulfate dihydrate as a delivery vehicle is readily resorbable, allows new bone formation, and can be combined with therapeutic agents. We compared the elution of daptomycin and tobramycin in calcium sulfate pellets over time and determined the dissolution rates of the pellets. Unlike other water-soluble antibiotics, daptomycin required special techniques to convert the calcium sulfate from a hemihydrate powder to a hardened dihydrate shape. The elution of daptomycin on day 1 (537 microg/mL/g) was greater than that from days 2, 3, 7, 10, 14, 21, and 28. The concentration fell to 153 microg/mL/g and 37 microg/mL/g on days 2 and 3, respectively, then remained at between 5 microg/mL/g and 7 microg/mL/g for the remainder of the study. The elution behavior of the daptomycin pellets differed from that of the tobramycin-containing pellets on days 1 through 3, but was similar from day 7 through day 28. Daptomycin-containing pellets dissolved more rapidly in vitro than tobramycin-containing pellets, although the importance of this more rapid dissolution in an in vivo situation is unknown. Using the techniques described in this paper, daptomycin can be incorporated within a calcium sulfate matrix.
authors.affiliation: Department of Biomedical Engineering, University of Memphis, Memphis, TN 38152-3210, USA.
authors.forename: Kelly C
authors.initials: KC
authors.lastname: Richelsoph
authors.forename: Nathan D
authors.initials: ND
authors.lastname: Webb
authors.forename: Warren O
authors.initials: WO
authors.lastname: Haggard
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002133:Calcium Sulfate; D017576:Daptomycin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004337:Drug Carriers; D004343:Drug Implants; D009140:Musculoskeletal Diseases / Q000188:drug therapy; D014031:Tobramycin / Q000008:administration & dosage / Q000493:pharmacokinetics*
chemical_list: D000900:Anti-Bacterial Agents; D004337:Drug Carriers; D004343:Drug Implants; D017576:Daptomycin; D014031:Tobramycin; D002133:Calcium Sulfate